Biomerica (BMRA) Change in Cash (2010 - 2026)

Biomerica (BMRA) has 17 years of Change in Cash data on file, last reported at -$1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash fell 275.95% year-over-year to -$1.2 million; the trailing twelve-month figure through Feb 2026 stood at -$1.7 million (up 23.88% YoY), and the FY2025 full-year result was -$1.8 million, up 68.1% from the prior year.
• Change in Cash declined to -$1.2 million in Q1 2026, from -$510000.0 in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $6.4 million in Q2 2023 to a low of -$4.3 million in Q2 2022.
• A 5-year average of -$344756.0 and a median of -$854000.0 in 2023 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash surged 823.37% in 2022 and tumbled 1195.57% in 2023, its largest moves.
• Tracing BMRA's Change in Cash over 5 years: stood at -$1.0 million in 2022, then gained by 15.28% to -$854000.0 in 2023, then jumped by 47.54% to -$448000.0 in 2024, then retreated by 13.84% to -$510000.0 in 2025, then plunged by 136.67% to -$1.2 million in 2026.
• Business Quant data shows BMRA's Change in Cash at -$1.2 million in Q1 2026, -$510000.0 in Q4 2025, and $654000.0 in Q3 2025.